Combat Disorders
25
0
0
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
8.0%
2 terminated out of 25 trials
90.5%
+4.0% vs benchmark
4%
1 trials in Phase 3/4
53%
10 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (25)
NightWare Randomized Trial 02
Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin
Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD
Long-term Health Outcomes of AE Casualties
Remote Study of NightWare for PTSD With Nightmares
NightWare Open Enrollment Study
Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)
An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military
Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
Quetiapine Augmentation for Treatment-resistant PTSD
A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel
Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
Vietnam Era Health Retrospective Observational Study
Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel
Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)
Trauma Management Therapy for OEF and OIF Combat Veterans
Reintegration: The Role of Spouse Telephone BATTLEMIND Pilot Study
FOCUS-CI: A Preventive Intervention With Children and Families of the Combat Injured
Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder